Company
Profile
Being
India’s largest multi-specialty pediatric hospital chain, Rainbow
Children’s Medicare Hospital started its operations in Hyderabad in
1999. They started themselves as pediatrics and now are a big
multi-specialty hospital chain. Being into pediatric, obstetrics, and
gynecology the company offers services including newborn and
pediatric intensive care, pediatric multi-specialty services,
pediatric Quaternary care, obstetric care, multidisciplinary fetal
care, perinatal genetic and fertility care.
Business
Information
As
of September 30, 2021, the company holds 14 hospitals and 3 clinics
in six cities with a capacity of 1500 beds. Moreover, the hospitals
have onboard 602 full-time doctors and 1686 visiting doctors. The
company ensured to have core specialists available 24/7 for
children’s emergencies, intensive care services, etc. With 18+
years of experience in pediatric health care and obstetrics and
gynecology, the company is heading forward to expand its operations
further.
Facts
About the Company
The
first hospital of Rainbow Group established its 50-bed pediatric
specialty in 1999 in Hyderabad by NRI doctor-turned entrepreneur Dr.
Ramesh Kancharla.
Amongst
all the existing competitors, Rainbow Group has the largest number
of hospital beds in the maternity and pediatric healthcare sector.
The
revenues of FY20 (Rs.719 Cr.) were higher than those of FY21 (Rs.650
Cr.). Seeing the growth prospects, the FY22’s half-year revenues
are standing at Rs.513 Cr. And the net profits of the first half
were Rs.81.22 Cr.
Points
to note before investing in Rainbow Children’s Medicare Ltd. IPO
The
company is backed by a UK-based CDC Group which started its
operation in 1999 from Hyderabad.
The
company focus on working with a doctor engagement model where the
core specialist doctors work on a full-time basis to deal with all
sort of emergencies neonatal and pediatric intensive care services.
Most
of its hired doctors are either trained or are qualified from the
United Kingdom, United States, Canada, and Australia, which helps
the hospital chain for better recognition in terms of services.
Also,
it holds strong experience in clinical medicare in complex diseases
and is one of the leading hospital chains in multi-specialty
healthcare.
It
also possesses a growing track record of its operational and
financial performance in all the services that it renders.
The
company holds a strong base in terms of having senior management and
has strong institutional shareholder support.
Grey
Market Premium (GMP)
Opening
Date | April
27, 2022 |
Closing
Date | April
29. 2022 |
Issue
Type | Book
Built Issue IPO |
Face
Value | ₹10
Per Equity Share |
Issue
Price | ₹516-542
Per Equity Share |
Lot
Size | 27
Shares |
IPO
Price | ₹1580.85
Cr. |
Listing
At | NSE,
BSE |
Allotment,
Listing & Refund Details
Finalization
of Basis of Allotment | May
5, 2022 |
Initiation
of Refund | May
6, 2022 |
Credit
of Equity Shares | May
9, 2022 |
Listing
Date | May
10, 2022 |
We
hope this information was helpful. For more details, you can post
your queries below and we will be happy to share them with you.
Thank
You!